The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CDK 4/6 inhibitors (CDKi) + endocrine therapy (ET) in ER-positive metastatic breast cancer (mBC) patients according ET sensitivity: A systematic review and meta-analysis.
 
Michela Piezzo
No Relationships to Disclose
 
Maria Riemma
No Relationships to Disclose
 
Daniela Cianniello
No Relationships to Disclose
 
Roberta Caputo
No Relationships to Disclose
 
Giuseppina Fusco
No Relationships to Disclose
 
Germira Di Gioia
No Relationships to Disclose
 
Ivana Cerillo
Travel, Accommodations, Expenses - Lilly; Pfizer; Roche
 
Marina Licenziato
No Relationships to Disclose
 
Gaetano Buonfanti
No Relationships to Disclose
 
Stefania Cocco
No Relationships to Disclose
 
Vincenzo Di Lauro
No Relationships to Disclose
 
Michelino De Laurentiis
Honoraria - Amgen; Celgene; Eisai; Lilly; Novartis; Pfizer; Roche
Consulting or Advisory Role - Amgen; Celgene; Eisai; Lilly; Novartis; Pfizer; Roche
Speakers' Bureau - Amgen; Celgene; Eisai; Lilly; Novartis; Pfizer; Roche
Research Funding - Eisai; Roche